Cencora, Inc.
Cencora, Inc. (COR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · COR · as of Jun 8, 2026
Key Statistics
Explore Cencora, Inc. Data
cor stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 46 · Buy rate: 71.7%
The COR analyst consensus is Buy, based on ratings from 46 Wall Street analysts over the past 3 months. The average 12-month price target is $389.29, representing +41.54% upside from the current price of $275.04.
Competitors & Peers
cor competitorsCOR
ARHCF
BDX
CAKFY
CQCQ
CVETStock Performance
Full HistoryAbout Cencora, Inc.
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceutica…
what is cencora, inc. · cor stock overview · cencora, inc. company profile · who is cencora, inc. ceo · cor NYSE · cencora, inc. headquarters · cencora, inc. business segments
About Stock Overview & Key Data
Cencora, Inc. (COR) is a Healthcare company in the Medical - Distribution industry, listed on NYSE since Apr 4, 1995. As of the latest trading session, COR stock price is $275.04, with a market capitalization of $53.5B. The stock has returned -3.14% over the past 12 months and -18.57% year-to-date.
According to 46 Wall Street analysts, the consensus rating for Cencora, Inc. stock is Buy, with an average 12-month price target of $389.29. In fiscal year 2025, Cencora, Inc. reported revenue of $321.3B and net income of $1.6B. For detailed data — including Cencora, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cencora, Inc. (COR) stock price is $275.04. The stock is traded on NYSE under the ticker symbol COR. The 52-week range is $244.82 – $377.54.